US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cadrenal Therapeutics, Inc.

1.57

-0.0400-2.48%

Post-market: 1.570.00000.00%16:10 EDT

Volume:36.24K

Turnover:57.21K

Market Cap:5.60M

PE:-0.32

High:1.69

Open:1.69

Low:1.54

Close:1.61

52wk High:14.64

52wk Low:1.54

Shares:3.57M

Float Shares:3.14M

Volume Ratio:0.66

T/O Rate:1.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8667

EPS(LYR):-6.6394

ROE:-275.16%

ROA:-125.93%

PB:1.37

PE(LYR):-0.24

Loading ...

Overview Company News Filings

Cadrenal Therapeutics Inc - Prospectus Filed for Resale of up to 1.2 Mln Shares of Common Stock by Selling Stockholders- SEC Filing

THOMSON REUTERS

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:43 AM

U.S. RESEARCH ROUNDUP-3M, CME Group, TransDigm Group

Cadrenal Therapeutics Inc : H.c. Wainwright Cuts Target Price to $13 From $32

THOMSON REUTERS

Cadrenal Therapeutics Inc trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:29 PM

Noble Financial Remains a Buy on Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics warrant holder exercises 571,430 warrants, generating $2.5 million proceeds

FDA Review Uncertainty Puts Cadrenal Therapeutics’ CAD-1005 Phase 3 Timeline and Costs at Risk

Cadrenal Therapeutics FY25 net loss widens to $13.2 million

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for Hit Following End-of-Phase 2 FDA Meeting

THOMSON REUTERS

Cadrenal highlights Phase 2 trial data showing CAD-1005 reduced thrombotic events in suspected HIT patients

Cadrenal Therapeutics Highlights Research Supporting 12-Lox Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes

THOMSON REUTERS

Cadrenal Therapeutics Inc expected to post a loss of $1.16 a share - Earnings Preview

Cadrenal Therapeutics highlights recent 12-LOX inhibitor platform expansion

Cadrenal Therapeutics Reports Phase 2 CAD-1005 HIT Data and Schedules End-of-Phase 2 Meeting

Cadrenal reports positive Phase 2 CAD-1005 data in heparin-induced thrombocytopenia trial

Cadrenal Therapeutics announces Phase 2 results for CAD-1005

BRIEF-Cadrenal Therapeutics Announces Phase 2 Results For CAD-1005

Cadrenal reports Phase 2 CAD-1005 trial cuts thrombotic events in HIT

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CVKD/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CVKD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":1.57,"timestamp":1787601600000,"preClose":1.61,"halted":0,"volume":36239,"hourTrading":{"tag":"盘后","latestPrice":1.57,"preClose":1.57,"latestTime":"16:10 EDT","volume":49,"amount":76.93,"timestamp":1787602205205,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02484472049689443,"floatShares":3142100,"shares":3567600,"eps":-4.866724,"marketStatus":"Post-Mkt","change":-0.04,"latestTime":"08-24 19:05:38 EDT","open":1.69,"high":1.69,"low":1.54,"amount":57210,"amplitude":0.093168,"askPrice":1.82,"askSize":100,"bidPrice":1.53,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-4.866724,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":1.61,"preHourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.61,"latestTime":"08:56 EDT","volume":29,"amount":47.559999999999995,"timestamp":1787576179047,"change":0.03,"changeRate":0.018634,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.57,"preClose":1.57,"latestTime":"16:10 EDT","volume":49,"amount":76.93,"timestamp":1787602205205,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.661518},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","floatShares":3142100,"roa":"-125.93%","roe":"-275.16%","lyrEps":-6.639405,"volumeRatio":0.661518,"shares":3567600,"dividePrice":0,"high":1.69,"amplitude":0.093168,"preClose":1.61,"low":1.54,"week52Low":1.54,"pbRate":"1.37","week52High":14.64,"institutionHeld":0,"latestPrice":1.57,"committee":-0.818182,"eps":-4.866724,"divideRate":0,"volume":36239,"delay":0,"ttmEps":-4.866724,"open":1.69,"prevYearClose":6.78,"prevWeekClose":1.61,"prevMonthClose":2.01,"prevQuarterClose":3.34,"fiveDayClose":1.76,"twentyDayClose":2.06,"sixtyDayClose":5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVKD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"CVKD","fiscalQuarterEnding":"2026/06","expectedEps":-1.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2026-05-07","symbol":"CVKD","fiscalQuarterEnding":"2026/03","expectedEps":-1.51,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2026-03-31","symbol":"CVKD","fiscalQuarterEnding":"2025/12","expectedEps":-1.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-11-10","symbol":"CVKD","fiscalQuarterEnding":"2025/09","expectedEps":-1.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2025-08-11","symbol":"CVKD","fiscalQuarterEnding":"2025/06","expectedEps":-1.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVKD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVKD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775620800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVKD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVKD","date":"2026-08-21","current":-0.324654,"percent":0.957324,"low":-6.5442,"twenty":-2.514854,"median":-1.460375,"eighty":-0.851932,"high":-0.407485,"avg":-1.772989,"sd":1.083908,"marketCap":5672471},"quantilePoints":[{"date":"2023-01-20","current":-6.5442,"twenty":-6.16384,"median":-5.593301,"eighty":-5.593301,"marketCap":47934449},{"date":"2023-01-27","current":-4.161603,"twenty":-5.973233,"median":-5.338088,"eighty":-4.549173,"marketCap":30482586},{"date":"2023-02-03","current":-3.812156,"twenty":-5.593301,"median":-4.511051,"eighty":-4.113951,"marketCap":27922980},{"date":"2023-02-10","current":-3.160912,"twenty":-5.38913,"median":-4.288675,"eighty":-3.488122,"marketCap":23152804},{"date":"2023-02-17","current":-3.573896,"twenty":-4.892266,"median":-4.082183,"eighty":-3.392818,"marketCap":26177793},{"date":"2023-02-24","current":-3.345166,"twenty":-4.587294,"median":-3.573896,"eighty":-3.380111,"marketCap":24502414},{"date":"2023-03-03","current":-2.875001,"twenty":-4.507652,"median":-3.569925,"eighty":-3.160912,"marketCap":21058580},{"date":"2023-03-10","current":-2.589089,"twenty":-4.478393,"median":-3.494476,"eighty":-3.058111,"marketCap":18964357},{"date":"2023-03-17","current":-2.271409,"twenty":-4.364918,"median":-3.399172,"eighty":-2.900415,"marketCap":16637442},{"date":"2023-03-24","current":-1.985498,"twenty":-4.145719,"median":-3.271465,"eighty":-2.525553,"marketCap":14543218},{"date":"2023-03-31","current":-2.239641,"twenty":-4.082183,"median":-3.15297,"eighty":-2.291105,"marketCap":16404750},{"date":"2023-04-06","current":-2.112569,"twenty":-4.082183,"median":-3.137086,"eighty":-2.249171,"marketCap":15473984},{"date":"2023-04-12","current":-2.229793,"twenty":-4.028178,"median":-3.11326,"eighty":-2.242818,"marketCap":16332616},{"date":"2023-04-21","current":-2.446133,"twenty":-3.866161,"median":-3.03114,"eighty":-2.237671,"marketCap":17917245},{"date":"2023-04-28","current":-2.366713,"twenty":-3.6692,"median":-2.946479,"eighty":-2.249171,"marketCap":17335516},{"date":"2023-05-05","current":-2.096686,"twenty":-3.573896,"median":-2.875001,"eighty":-2.188781,"marketCap":15357639},{"date":"2023-05-12","current":-1.444685,"twenty":-3.573896,"median":-2.612915,"eighty":-2.169752,"marketCap":17800899},{"date":"2023-05-19","current":-1.359704,"twenty":-3.569131,"median":-2.462017,"eighty":-2.077625,"marketCap":16753788},{"date":"2023-05-26","current":-1.284383,"twenty":-3.546035,"median":-2.446133,"eighty":-1.985498,"marketCap":15825717},{"date":"2023-06-02","current":-1.346224,"twenty":-3.517444,"median":-2.384186,"eighty":-1.928316,"marketCap":16587696},{"date":"2023-06-09","current":-1.503204,"twenty":-3.469062,"median":-2.334945,"eighty":-1.45944,"marketCap":18521951},{"date":"2023-06-16","current":-1.44612,"twenty":-3.43094,"median":-2.283322,"eighty":-1.45944,"marketCap":17818586},{"date":"2023-06-23","current":-1.484176,"twenty":-3.418233,"median":-2.263467,"eighty":-1.465148,"marketCap":18287496},{"date":"2023-06-30","current":-1.398551,"twenty":-3.367404,"median":-2.247583,"eighty":-1.465148,"marketCap":17232448},{"date":"2023-07-07","current":-1.417578,"twenty":-3.349614,"median":-2.226775,"eighty":-1.445833,"marketCap":17466903},{"date":"2023-07-14","current":-1.503299,"twenty":-3.286205,"median":-2.191989,"eighty":-1.443298,"marketCap":18523123},{"date":"2023-07-21","current":-1.637011,"twenty":-3.183023,"median":-2.150431,"eighty":-1.445833,"marketCap":20170670},{"date":"2023-07-28","current":-1.152922,"twenty":-3.160912,"median":-2.112569,"eighty":-1.436606,"marketCap":14205899},{"date":"2023-08-04","current":-1.14188,"twenty":-3.148205,"median":-2.045063,"eighty":-1.406161,"marketCap":14069843},{"date":"2023-08-11","current":-0.924489,"twenty":-3.132321,"median":-1.985498,"eighty":-1.379336,"marketCap":11854271},{"date":"2023-08-18","current":-0.791165,"twenty":-3.116437,"median":-1.961672,"eighty":-1.351057,"marketCap":10144725},{"date":"2023-08-25","current":-0.756633,"twenty":-3.058111,"median":-1.906237,"eighty":-1.33893,"marketCap":9701938},{"date":"2023-09-01","current":-0.782025,"twenty":-3.028503,"median":-1.714964,"eighty":-1.314525,"marketCap":10027520},{"date":"2023-09-08","current":-0.93325,"twenty":-2.992542,"median":-1.675857,"eighty":-1.277692,"marketCap":11966608},{"date":"2023-09-15","current":-0.791064,"twenty":-2.948067,"median":-1.596605,"eighty":-1.146297,"marketCap":10143423},{"date":"2023-09-22","current":-0.685541,"twenty":-2.919476,"median":-1.522232,"eighty":-1.104853,"marketCap":8790358},{"date":"2023-09-29","current":-0.680463,"twenty":-2.884531,"median":-1.503251,"eighty":-0.944749,"marketCap":8725245},{"date":"2023-10-06","current":-0.665229,"twenty":-2.792404,"median":-1.503204,"eighty":-0.904366,"marketCap":8529903},{"date":"2023-10-13","current":-0.649081,"twenty":-2.655802,"median":-1.479419,"eighty":-0.871399,"marketCap":8322842},{"date":"2023-10-20","current":-0.597183,"twenty":-2.61768,"median":-1.473616,"eighty":-0.791104,"marketCap":7657379},{"date":"2023-10-27","current":-0.503746,"twenty":-2.598619,"median":-1.465148,"eighty":-0.784463,"marketCap":6459285},{"date":"2023-11-03","current":-0.446871,"twenty":-2.525553,"median":-1.450877,"eighty":-0.769227,"marketCap":5730011},{"date":"2023-11-10","current":-0.446511,"twenty":-2.471547,"median":-1.444685,"eighty":-0.749525,"marketCap":5730011},{"date":"2023-11-17","current":-0.457674,"twenty":-2.462017,"median":-1.436606,"eighty":-0.722103,"marketCap":5873262},{"date":"2023-11-22","current":-0.507704,"twenty":-2.455663,"median":-1.417578,"eighty":-0.721088,"marketCap":6515283},{"date":"2023-12-01","current":-0.466807,"twenty":-2.446133,"median":-1.403307,"eighty":-0.699922,"marketCap":5990466},{"date":"2023-12-08","current":-0.471881,"twenty":-2.427072,"median":-1.388031,"eighty":-0.680463,"marketCap":6055580},{"date":"2023-12-15","current":-0.559052,"twenty":-2.387045,"median":-1.376708,"eighty":-0.648167,"marketCap":7174222},{"date":"2023-12-22","current":-0.56514,"twenty":-2.368619,"median":-1.351076,"eighty":-0.63015,"marketCap":7252358},{"date":"2023-12-29","current":-0.722638,"twenty":-2.366713,"median":-1.348603,"eighty":-0.629682,"marketCap":9273503},{"date":"2024-01-05","current":-0.635264,"twenty":-2.347652,"median":-1.341467,"eighty":-0.629743,"marketCap":8152244},{"date":"2024-01-12","current":-0.620651,"twenty":-2.315884,"median":-1.326907,"eighty":-0.629682,"marketCap":7964716},{"date":"2024-01-19","current":-0.953911,"twenty":-2.296823,"median":-1.312673,"eighty":-0.629723,"marketCap":12241388},{"date":"2024-01-26","current":-1.319238,"twenty":-2.284116,"median":-1.293897,"eighty":-0.63015,"marketCap":16929580},{"date":"2024-02-02","current":-1.430866,"twenty":-2.276174,"median":-1.320586,"eighty":-0.632524,"marketCap":18362083},{"date":"2024-02-09","current":-0.923467,"twenty":-2.265055,"median":-1.321934,"eighty":-0.637094,"marketCap":11850706},{"date":"2024-02-16","current":-0.791644,"twenty":-2.255525,"median":-1.298654,"eighty":-0.640854,"marketCap":10159050},{"date":"2024-02-23","current":-0.743847,"twenty":-2.252348,"median":-1.278807,"eighty":-0.643003,"marketCap":9545678},{"date":"2024-03-01","current":-0.714418,"twenty":-2.237671,"median":-1.221262,"eighty":-0.639426,"marketCap":9168018},{"date":"2024-03-08","current":-0.654241,"twenty":-2.228586,"median":-1.149822,"eighty":-0.640346,"marketCap":8395769},{"date":"2024-03-15","current":-1.139373,"twenty":-2.218452,"median":-1.14188,"eighty":-0.642618,"marketCap":9521837},{"date":"2024-03-22","current":-1.2068,"twenty":-2.196183,"median":-1.140626,"eighty":-0.643971,"marketCap":10085335},{"date":"2024-03-28","current":-1.225937,"twenty":-2.191989,"median":-1.148028,"eighty":-0.645513,"marketCap":10245260},{"date":"2024-04-05","current":-1.16485,"twenty":-2.176105,"median":-1.152922,"eighty":-0.647557,"marketCap":9734749},{"date":"2024-04-12","current":-0.835183,"twenty":-2.160222,"median":-1.146113,"eighty":-0.649081,"marketCap":6979692},{"date":"2024-04-19","current":-0.823306,"twenty":-2.140639,"median":-1.139373,"eighty":-0.654241,"marketCap":6880439},{"date":"2024-04-26","current":-0.81143,"twenty":-2.128453,"median":-1.124432,"eighty":-0.658604,"marketCap":6781187},{"date":"2024-05-03","current":-0.890734,"twenty":-2.112569,"median":-1.111003,"eighty":-0.664084,"marketCap":7443938},{"date":"2024-05-10","current":-0.929811,"twenty":-2.096686,"median":-1.0981,"eighty":-0.664287,"marketCap":7770510},{"date":"2024-05-17","current":-1.420575,"twenty":-2.049034,"median":-1.111003,"eighty":-0.665229,"marketCap":6885242},{"date":"2024-05-24","current":-1.383913,"twenty":-2.041092,"median":-1.124432,"eighty":-0.669767,"marketCap":6707548},{"date":"2024-05-31","current":-1.354187,"twenty":-2.034738,"median":-1.135559,"eighty":-0.672852,"marketCap":6563472},{"date":"2024-06-07","current":-1.651117,"twenty":-1.995028,"median":-1.145503,"eighty":-0.674597,"marketCap":8002633},{"date":"2024-06-14","current":-1.462522,"twenty":-1.985498,"median":-1.149334,"eighty":-0.676934,"marketCap":7088550},{"date":"2024-06-21","current":-1.516029,"twenty":-1.985498,"median":-1.156171,"eighty":-0.679183,"marketCap":7347887},{"date":"2024-06-28","current":-1.504138,"twenty":-1.985498,"median":-1.16485,"eighty":-0.680036,"marketCap":7290256},{"date":"2024-07-05","current":-1.592623,"twenty":-1.956907,"median":-1.185729,"eighty":-0.680463,"marketCap":7719123},{"date":"2024-07-12","current":-1.549057,"twenty":-1.928316,"median":-1.2068,"eighty":-0.68257,"marketCap":7507971},{"date":"2024-07-15","current":-1.520322,"twenty":-1.925139,"median":-1.2068,"eighty":-0.683272,"marketCap":7368698},{"date":"2024-08-02","current":-1.416942,"twenty":-1.921962,"median":-1.214031,"eighty":-0.683974,"marketCap":6867633},{"date":"2024-08-09","current":-1.111674,"twenty":-1.906237,"median":-1.225937,"eighty":-0.685541,"marketCap":6933267},{"date":"2024-08-16","current":-1.293659,"twenty":-1.846933,"median":-1.234183,"eighty":-0.690721,"marketCap":8068268},{"date":"2024-08-23","current":-1.172164,"twenty":-1.818901,"median":-1.225937,"eighty":-0.699354,"marketCap":7310532},{"date":"2024-08-30","current":-1.264569,"twenty":-1.714964,"median":-1.241521,"eighty":-0.700775,"marketCap":7886837},{"date":"2024-09-06","current":-1.377507,"twenty":-1.706882,"median":-1.245795,"eighty":-0.702272,"marketCap":8591209},{"date":"2024-09-13","current":-1.830972,"twenty":-1.706882,"median":-1.246644,"eighty":-0.711712,"marketCap":11419371},{"date":"2024-09-20","current":-1.918243,"twenty":-1.834164,"median":-1.261146,"eighty":-0.71433,"marketCap":11963659},{"date":"2024-09-27","current":-2.482935,"twenty":-1.908638,"median":-1.273231,"eighty":-0.715692,"marketCap":15485521},{"date":"2024-10-04","current":-1.950755,"twenty":-1.957258,"median":-1.289021,"eighty":-0.720072,"marketCap":12166433},{"date":"2024-10-11","current":-1.928578,"twenty":-1.985498,"median":-1.30307,"eighty":-0.721088,"marketCap":12028120},{"date":"2024-10-18","current":-2.789238,"twenty":-2.037954,"median":-1.318426,"eighty":-0.721575,"marketCap":17395865},{"date":"2024-10-25","current":-2.86453,"twenty":-2.049228,"median":-1.322439,"eighty":-0.722103,"marketCap":17865446},{"date":"2024-10-31","current":-3.933452,"twenty":-2.070731,"median":-1.331376,"eighty":-0.722465,"marketCap":24532076},{"date":"2024-11-08","current":-3.909452,"twenty":-2.133327,"median":-1.338437,"eighty":-0.727802,"marketCap":24382399},{"date":"2024-11-15","current":-3.259855,"twenty":-2.194086,"median":-1.341467,"eighty":-0.734352,"marketCap":24801495},{"date":"2024-11-22","current":-3.282348,"twenty":-2.233732,"median":-1.351028,"eighty":-0.73941,"marketCap":24972628},{"date":"2024-11-29","current":-3.558806,"twenty":-2.265055,"median":-1.353013,"eighty":-0.74173,"marketCap":27075962},{"date":"2024-12-06","current":-3.132405,"twenty":-2.307334,"median":-1.357489,"eighty":-0.742873,"marketCap":23831837},{"date":"2024-12-13","current":-2.717719,"twenty":-2.368619,"median":-1.360113,"eighty":-0.745058,"marketCap":20676837},{"date":"2024-12-20","current":-3.394806,"twenty":-2.438951,"median":-1.363105,"eighty":-0.747693,"marketCap":25828222},{"date":"2024-12-27","current":-3.854006,"twenty":-2.462017,"median":-1.369978,"eighty":-0.749448,"marketCap":29321894},{"date":"2025-01-03","current":-3.631435,"twenty":-2.481224,"median":-1.377507,"eighty":-0.751556,"marketCap":27628533},{"date":"2025-01-10","current":-3.877435,"twenty":-2.523165,"median":-1.379523,"eighty":-0.753182,"marketCap":29500143},{"date":"2025-01-17","current":-4.264007,"twenty":-2.624538,"median":-1.387215,"eighty":-0.756024,"marketCap":32441245},{"date":"2025-01-24","current":-4.636522,"twenty":-2.674136,"median":-1.387903,"eighty":-0.758704,"marketCap":35275397},{"date":"2025-01-31","current":-4.458465,"twenty":-2.840559,"median":-1.398551,"eighty":-0.76167,"marketCap":33920708},{"date":"2025-02-07","current":-4.474865,"twenty":-2.909946,"median":-1.409317,"eighty":-0.766663,"marketCap":34045482},{"date":"2025-02-14","current":-4.49595,"twenty":-2.953876,"median":-1.417578,"eighty":-0.770226,"marketCap":34205906},{"date":"2025-02-21","current":-4.50415,"twenty":-3.001398,"median":-1.420575,"eighty":-0.772831,"marketCap":34268293},{"date":"2025-02-28","current":-4.313207,"twenty":-3.066784,"median":-1.427287,"eighty":-0.777478,"marketCap":32815567},{"date":"2025-03-07","current":-3.912578,"twenty":-3.139979,"median":-1.436606,"eighty":-0.780079,"marketCap":29767516},{"date":"2025-03-14","current":-4.088293,"twenty":-3.197171,"median":-1.445403,"eighty":-0.780934,"marketCap":31104380},{"date":"2025-03-21","current":-3.441281,"twenty":-3.248668,"median":-1.453604,"eighty":-0.782025,"marketCap":36654345},{"date":"2025-03-28","current":-3.301865,"twenty":-3.277995,"median":-1.456931,"eighty":-0.78237,"marketCap":35169374},{"date":"2025-04-04","current":-2.968325,"twenty":-3.266821,"median":-1.464503,"eighty":-0.783762,"marketCap":31616722},{"date":"2025-04-11","current":-2.518311,"twenty":-3.259068,"median":-1.469382,"eighty":-0.787263,"marketCap":26823461},{"date":"2025-04-17","current":-2.85891,"twenty":-3.257859,"median":-1.474662,"eighty":-0.790653,"marketCap":30451302},{"date":"2025-04-25","current":-3.000091,"twenty":-3.257392,"median":-1.49369,"eighty":-0.791084,"marketCap":31955070},{"date":"2025-05-02","current":-2.911853,"twenty":-3.251752,"median":-1.503204,"eighty":-0.791261,"marketCap":31015215},{"date":"2025-05-09","current":-2.270277,"twenty":-3.230283,"median":-1.504138,"eighty":-0.792361,"marketCap":29135505},{"date":"2025-05-16","current":-2.217562,"twenty":-3.211785,"median":-1.51768,"eighty":-0.795364,"marketCap":28458997},{"date":"2025-05-23","current":-2.303286,"twenty":-3.207473,"median":-1.520322,"eighty":-0.798283,"marketCap":29559125},{"date":"2025-05-30","current":-2.048131,"twenty":-3.194675,"median":-1.522232,"eighty":-0.80779,"marketCap":26284611},{"date":"2025-06-06","current":-2.238922,"twenty":-3.17692,"median":-1.535185,"eighty":-0.81143,"marketCap":28733121},{"date":"2025-06-13","current":-2.297156,"twenty":-3.160912,"median":-1.541956,"eighty":-0.811839,"marketCap":29480458},{"date":"2025-06-20","current":-2.051962,"twenty":-3.160912,"median":-1.546017,"eighty":-0.812362,"marketCap":26333778},{"date":"2025-06-27","current":-1.575368,"twenty":-3.148205,"median":-1.553351,"eighty":-0.816087,"marketCap":20217419},{"date":"2025-07-03","current":-1.989132,"twenty":-3.137454,"median":-1.556427,"eighty":-0.819168,"marketCap":25527441},{"date":"2025-07-11","current":-1.992197,"twenty":-3.130448,"median":-1.575368,"eighty":-0.822233,"marketCap":25566775},{"date":"2025-07-18","current":-1.819029,"twenty":-3.122655,"median":-1.585907,"eighty":-0.824111,"marketCap":23344432},{"date":"2025-07-25","current":-1.748536,"twenty":-3.115288,"median":-1.592623,"eighty":-0.830969,"marketCap":22439761},{"date":"2025-08-01","current":-1.596822,"twenty":-3.112066,"median":-1.60755,"eighty":-0.83978,"marketCap":20492753},{"date":"2025-08-08","current":-1.687442,"twenty":-3.09327,"median":-1.615212,"eighty":-0.845488,"marketCap":21655715},{"date":"2025-08-15","current":-1.874525,"twenty":-3.081005,"median":-1.616467,"eighty":-0.850297,"marketCap":26445353},{"date":"2025-08-22","current":-1.806334,"twenty":-3.070504,"median":-1.637011,"eighty":-0.858896,"marketCap":25483332},{"date":"2025-08-29","current":-1.928207,"twenty":-3.05288,"median":-1.651282,"eighty":-0.863774,"marketCap":27202689},{"date":"2025-09-05","current":-1.815039,"twenty":-3.045161,"median":-1.654092,"eighty":-0.866712,"marketCap":25606143},{"date":"2025-09-12","current":-1.958675,"twenty":-3.041134,"median":-1.665783,"eighty":-0.875806,"marketCap":27632529},{"date":"2025-09-19","current":-1.935461,"twenty":-3.028991,"median":-1.685629,"eighty":-0.883586,"marketCap":27305032},{"date":"2025-09-26","current":-2.060236,"twenty":-3.01081,"median":-1.701972,"eighty":-0.884716,"marketCap":29065326},{"date":"2025-10-03","current":-2.058785,"twenty":-2.99162,"median":-1.71336,"eighty":-0.887838,"marketCap":29044858},{"date":"2025-10-10","current":-2.058785,"twenty":-2.977972,"median":-1.730146,"eighty":-0.89028,"marketCap":29044858},{"date":"2025-10-17","current":-2.005828,"twenty":-2.973266,"median":-1.744222,"eighty":-0.89604,"marketCap":28297756},{"date":"2025-10-24","current":-1.997849,"twenty":-2.966913,"median":-1.748536,"eighty":-0.904366,"marketCap":28185179},{"date":"2025-10-31","current":-1.874525,"twenty":-2.963428,"median":-1.767691,"eighty":-0.910735,"marketCap":26445353},{"date":"2025-11-07","current":-1.770062,"twenty":-2.961332,"median":-1.774587,"eighty":-0.921067,"marketCap":24971618},{"date":"2025-11-14","current":-1.657615,"twenty":-2.959148,"median":-1.761439,"eighty":-0.923876,"marketCap":23845849},{"date":"2025-11-21","current":-1.630588,"twenty":-2.955352,"median":-1.753133,"eighty":-0.926618,"marketCap":23457048},{"date":"2025-11-28","current":-1.354629,"twenty":-2.954378,"median":-1.747124,"eighty":-0.930499,"marketCap":19487202},{"date":"2025-12-05","current":-1.601728,"twenty":-2.954068,"median":-1.744222,"eighty":-0.934516,"marketCap":23041879},{"date":"2025-12-12","current":-1.587298,"twenty":-2.950868,"median":-1.73848,"eighty":-0.939656,"marketCap":22834295},{"date":"2025-12-19","current":-1.063489,"twenty":-2.940291,"median":-1.726315,"eighty":-0.940873,"marketCap":15298977},{"date":"2025-12-26","current":-1.063489,"twenty":-2.940291,"median":-1.71823,"eighty":-0.944523,"marketCap":15298977},{"date":"2026-01-02","current":-1.101967,"twenty":-2.938888,"median":-1.708991,"eighty":-0.944976,"marketCap":15852501},{"date":"2026-01-09","current":-1.280752,"twenty":-2.91719,"median":-1.701972,"eighty":-0.952147,"marketCap":18424440},{"date":"2026-01-16","current":-1.332762,"twenty":-2.904794,"median":-1.687875,"eighty":-0.957005,"marketCap":19172641},{"date":"2026-01-23","current":-1.241744,"twenty":-2.899853,"median":-1.679836,"eighty":-0.969272,"marketCap":17863290},{"date":"2026-01-30","current":-1.212489,"twenty":-2.893625,"median":-1.665783,"eighty":-0.98096,"marketCap":17442427},{"date":"2026-02-06","current":-0.867921,"twenty":-2.886524,"median":-1.656007,"eighty":-0.98096,"marketCap":12485598},{"date":"2026-02-13","current":-0.880923,"twenty":-2.881499,"median":-1.651447,"eighty":-0.944863,"marketCap":12672648},{"date":"2026-02-20","current":-1.009324,"twenty":-2.878053,"median":-1.641539,"eighty":-0.941701,"marketCap":14519768},{"date":"2026-02-27","current":-1.362018,"twenty":-2.873859,"median":-1.62773,"eighty":-0.944396,"marketCap":19593504},{"date":"2026-03-06","current":-1.299443,"twenty":-2.8691,"median":-1.617721,"eighty":-0.944749,"marketCap":18693325},{"date":"2026-03-13","current":-1.16698,"twenty":-2.862282,"median":-1.60245,"eighty":-0.948618,"marketCap":16787751},{"date":"2026-03-20","current":-1.132848,"twenty":-2.857498,"median":-1.596822,"eighty":-0.955458,"marketCap":16296745},{"date":"2026-03-27","current":-0.851668,"twenty":-2.854674,"median":-1.589961,"eighty":-0.944749,"marketCap":12251785},{"date":"2026-04-02","current":-0.865491,"twenty":-2.853417,"median":-1.587275,"eighty":-0.939656,"marketCap":11456822},{"date":"2026-04-10","current":-0.941191,"twenty":-2.848599,"median":-1.585719,"eighty":-0.93011,"marketCap":12458880},{"date":"2026-04-17","current":-0.918466,"twenty":-2.823863,"median":-1.582965,"eighty":-0.926432,"marketCap":12158062},{"date":"2026-04-24","current":-1.04724,"twenty":-2.784819,"median":-1.573829,"eighty":-0.927082,"marketCap":13862698},{"date":"2026-05-01","current":-1.551057,"twenty":-2.759024,"median":-1.555271,"eighty":-0.929709,"marketCap":20531907},{"date":"2026-05-08","current":-1.399905,"twenty":-2.724786,"median":-1.551057,"eighty":-0.93011,"marketCap":18531046},{"date":"2026-05-15","current":-1.36454,"twenty":-2.71069,"median":-1.547537,"eighty":-0.931696,"marketCap":16222361},{"date":"2026-05-22","current":-1.338647,"twenty":-2.679763,"median":-1.541956,"eighty":-0.934516,"marketCap":15914536},{"date":"2026-05-29","current":-1.29463,"twenty":-2.668509,"median":-1.537105,"eighty":-0.93958,"marketCap":15391235},{"date":"2026-06-05","current":-1.115971,"twenty":-2.647139,"median":-1.531678,"eighty":-0.939961,"marketCap":13267244},{"date":"2026-06-12","current":-1.043472,"twenty":-2.647139,"median":-1.522232,"eighty":-0.941191,"marketCap":12405335},{"date":"2026-06-18","current":-0.747912,"twenty":-2.638821,"median":-1.519662,"eighty":-0.938314,"marketCap":8891565},{"date":"2026-06-26","current":-0.690009,"twenty":-2.628688,"median":-1.514039,"eighty":-0.929033,"marketCap":8203186},{"date":"2026-07-02","current":-0.7648,"twenty":-2.625072,"median":-1.503718,"eighty":-0.92408,"marketCap":9092342},{"date":"2026-07-10","current":-0.726198,"twenty":-2.614313,"median":-1.503204,"eighty":-0.915436,"marketCap":8633423},{"date":"2026-07-17","current":-0.56214,"twenty":-2.59754,"median":-1.488933,"eighty":-0.902969,"marketCap":6683015},{"date":"2026-07-24","current":-0.489762,"twenty":-2.58972,"median":-1.474662,"eighty":-0.890464,"marketCap":5822541},{"date":"2026-07-31","current":-0.504237,"twenty":-2.586191,"median":-1.473616,"eighty":-0.884716,"marketCap":5994636},{"date":"2026-08-07","current":-0.45116,"twenty":-2.579965,"median":-1.46932,"eighty":-0.880724,"marketCap":5363621},{"date":"2026-08-14","current":-0.448747,"twenty":-2.553613,"median":-1.465148,"eighty":-0.866463,"marketCap":5334939},{"date":"2026-08-21","current":-0.491387,"twenty":-2.514854,"median":-1.460375,"eighty":-0.851932,"marketCap":5672471}],"updateTime":1787595427676},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVKD\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629832087","title":"Cadrenal Therapeutics Inc - Prospectus Filed for Resale of up to 1.2 Mln Shares of Common Stock by Selling Stockholders- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629832087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629832087?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:04","pubTimestamp":1776765842,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nFWN41409J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628220717","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:43 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2628220717","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628220717?lang=en_us&edition=fundamental","pubTime":"2026-04-17 22:43","pubTimestamp":1776437039,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:43 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nAQN2LV51A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625288916","title":"U.S. RESEARCH ROUNDUP-3M, CME Group, TransDigm Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2625288916","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625288916?lang=en_us&edition=fundamental","pubTime":"2026-04-08 16:13","pubTimestamp":1775635990,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-3M, CME Group, TransDigm GroupApril 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including 3M, CME Grou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4N40R0OK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","GPN","CRS","DHR","BMI","AMG","LU0708994859.HKD","CATY","IQV","ARES","CFG","TDG","GE","BOEU","IEX","SCHW","FITB","CRL","CARR","DOV","EWBC","HEI","BAM","CL","FTV","ATI","CG","BLK","AX","CFR","CVKD","AME","EMR","CME","IE00B66KJ199.SGD","KKR","WMS","SG9999014021.USD","MMM","DE","APO","CBOE","BOED","BOEG","BA","ATKR","FCNCA","LU0672654240.SGD","BX","FLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625996925","title":"Cadrenal Therapeutics Inc : H.c. Wainwright Cuts Target Price to $13 From $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2625996925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625996925?lang=en_us&edition=fundamental","pubTime":"2026-04-08 10:58","pubTimestamp":1775617100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40Q0X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624467305","title":"Cadrenal Therapeutics Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2624467305","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624467305?lang=en_us&edition=fundamental","pubTime":"2026-04-02 03:36","pubTimestamp":1775072209,"startTime":"0","endTime":"0","summary":"15:29 EDT Cadrenal Therapeutics (CVKD) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","CVKD","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624125546","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:29 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2624125546","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624125546?lang=en_us&edition=fundamental","pubTime":"2026-04-02 03:29","pubTimestamp":1775071770,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:29 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nAQN2LSVV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624511715","title":"Noble Financial Remains a Buy on Cadrenal Therapeutics, Inc. (CVKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624511715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624511715?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:56","pubTimestamp":1775051765,"startTime":"0","endTime":"0","summary":"In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Cadrenal Therapeutics, Inc., with a price target of $45....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/noble-financial-remains-a-buy-on-cadrenal-therapeutics-inc-cvkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/noble-financial-remains-a-buy-on-cadrenal-therapeutics-inc-cvkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NBL","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624511518","title":"Cadrenal Therapeutics warrant holder exercises 571,430 warrants, generating $2.5 million proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2624511518","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624511518?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:41","pubTimestamp":1775043673,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics entered warrant inducement agreement March 31, 2026 covering cash exercise of existing warrants for 571,430 common shares at $4.50 per share.Transaction expected to close April 1, 2026 with gross proceeds of about $2.5 million.Incentive package includes issuance of unregistered Series B-1 warrants for 571,430 shares, exercisable at $4.50 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDLb80xKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624564407","title":"FDA Review Uncertainty Puts Cadrenal Therapeutics’ CAD-1005 Phase 3 Timeline and Costs at Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2624564407","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624564407?lang=en_us&edition=fundamental","pubTime":"2026-04-01 14:00","pubTimestamp":1775023212,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc. (CVKD) has disclosed a new risk, in the Innovation / R&D category. Cadrenal Therapeutics, Inc. faces uncertainty becaus...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-review-uncertainty-puts-cadrenal-therapeutics-cad-1005-phase-3-timeline-and-costs-at-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-review-uncertainty-puts-cadrenal-therapeutics-cad-1005-phase-3-timeline-and-costs-at-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","CVKD","LABU","LENZ","BK4139","BK4007","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555624","title":"Cadrenal Therapeutics FY25 net loss widens to $13.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555624","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555624?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:38","pubTimestamp":1774993107,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics posted a net loss of $3 million for Q4 2025, narrowing from $4.2 million year earlier.Research and development expense dropped to $0.7 million from $1.5 million.General and administrative costs eased to $2.4 million from $2.7 million.CAD-1005 Phase 2 study in suspected HIT showed more than a 25 percentage point reduction in thrombotic events versus placebo on background anticoagulants, while suggesting platelet count recovery may not be a suitable efficacy surrogate.Company completed End-of-Phase 2 FDA meeting on March 26, 2026, aligning on a potential registrational path for a Phase 3 pivotal trial, with protocol updates incorporating FDA feedback underway.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL75th7T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","IE00BN0W2T93.GBP","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","BK4007","BK4588","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","LU2210150020.SGD","LU2210149790.SGD","IE00BKPKM429.USD","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623581467","title":"Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for Hit Following End-of-Phase 2 FDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2623581467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623581467?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:45","pubTimestamp":1774961100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA8ZGSZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618349901","title":"Cadrenal highlights Phase 2 trial data showing CAD-1005 reduced thrombotic events in suspected HIT patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2618349901","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618349901?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:08","pubTimestamp":1773317294,"startTime":"0","endTime":"0","summary":"Cadrenal reported preclinical findings indicating that its 12-lipoxygenase  inhibitor CAD-1005 reduced inflammation-related effects in models of obesity and type 2 diabetes. The company said oral CAD-1005 improved glycemic control and reduced pancreatic β-cell loss in these models. It also reported reductions in inflammatory cells in adipose and pancreatic tissues, along with lower pro-inflammatory cytokines in adipose tissue. Separately, Cadrenal said results from a recent Phase 2 trial of CAD-1005 in suspected heparin-induced thrombocytopenia showed a reduction in thrombotic events, and these results were presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL8Kkd09:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","BK4112","BK4007","CVKD","SG9999014005.SGD","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","BK4585","LU2210149790.SGD","LU2095319765.USD","IE00B64PRP62.GBP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618813140","title":"Cadrenal Therapeutics Highlights Research Supporting 12-Lox Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2618813140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618813140?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:01","pubTimestamp":1773316869,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4001RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618167436","title":"Cadrenal Therapeutics Inc  expected to post a loss of $1.16 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618167436","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618167436?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:07","pubTimestamp":1773086825,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc  expected to post a loss of $1.16 a share - Earnings Preview Cadrenal Therapeutics Inc CVKD.OQ CVKD.O is expected to  show no change in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL8N3ZX29N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616330917","title":"Cadrenal Therapeutics highlights recent 12-LOX inhibitor platform expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2616330917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616330917?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:37","pubTimestamp":1772458673,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics (CVKD) provided additional perspectives on development opportunities following its recent pipeline expansion with the additio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-highlights-recent-12-lox-inhibitor-platform-expansion-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-highlights-recent-12-lox-inhibitor-platform-expansion-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CVKD","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616373973","title":"Cadrenal Therapeutics Reports Phase 2 CAD-1005 HIT Data and Schedules End-of-Phase 2 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2616373973","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616373973?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:11","pubTimestamp":1772457087,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc. said it expanded its pipeline by acquiring a portfolio of selective 12-LOX inhibitors, including oral candidates. The company reported encouraging data from a blinded, placebo-controlled Phase 2 study of CAD-1005, a parenteral 12-LOX inhibitor, in heparin-induced thrombocytopenia, showing a reduction in thrombotic events on a background of standard anticoagulants. Cadrenal said an End-of-Phase 2 meeting is scheduled for later this month, and it cited additional potential 12-LOX-related opportunities in areas including atherosclerosis and vascular inflammation, microvascular thrombosis, ischemia-reperfusion injury, and immune-mediated metabolic conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrena","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL4SXKvw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332205","title":"Cadrenal reports positive Phase 2 CAD-1005 data in heparin-induced thrombocytopenia trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332205","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332205?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:02","pubTimestamp":1772456547,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc. reported encouraging results from a blinded, placebo-controlled Phase 2 clinical study of CAD-1005, a parenteral selective 12-LOX inhibitor, in heparin-induced thrombocytopenia, showing a reduction in thrombotic events on a background of standard anticoagulants. The company said an End-of-Phase 2 meeting is scheduled for later this month  to discuss next steps for its lead indication, while it also evaluates additional acute and chronic opportunities for 12-LOX inhibition beyond heparin-induced thrombocytopenia.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL1F71W3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","NDAQ","LU2210149790.SGD","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","IE00B64PRP62.GBP","CVKD","BK4112","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613685712","title":"Cadrenal Therapeutics announces Phase 2 results for CAD-1005","url":"https://stock-news.laohu8.com/highlight/detail?id=2613685712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613685712?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:39","pubTimestamp":1771940372,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics (CVKD) announced results from a Phase 2 trial evaluating CAD-1005 in patients with heparin-induced thrombocytopenia, a severe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-announces-phase-2-results-for-cad-1005-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-announces-phase-2-results-for-cad-1005-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVKD","LENZ","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613071477","title":"BRIEF-Cadrenal Therapeutics Announces Phase 2 Results For CAD-1005","url":"https://stock-news.laohu8.com/highlight/detail?id=2613071477","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613071477?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:32","pubTimestamp":1771939965,"startTime":"0","endTime":"0","summary":"BRIEF-Cadrenal Therapeutics Announces Phase 2 Results For CAD-1005Feb 24 (Reuters) - Cadrenal Therapeutics Inc CVKD.O:CADRENAL THERAPEUTICS ANNOUNCES PHASE 2 RESULTS WITH ENCOURAGING  REDUCTIONS IN TH","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0PV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613714223","title":"Cadrenal reports Phase 2 CAD-1005 trial cuts thrombotic events in HIT","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714223?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:30","pubTimestamp":1771939840,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc. reported results from a randomized, blinded, placebo-controlled Phase 2 trial of CAD-1005 , a selective 12-lipoxygenase inhibitor, in patients with heparin-induced thrombocytopenia receiving standard anticoagulant therapy. The study did not meet its primary endpoint of platelet count recovery, which was similar between CAD-1005 and placebo. As a key secondary endpoint, the incidence of new or worsening thrombotic events was 50% in the CAD-1005 arm versus more than 75% in the placebo arm; the trial was not powered for statistical significance. The company said detailed trial results will be presented at a future scientific meeting and that an End-of-Phase 2 FDA meeting is scheduled for March 2026 to discuss a Phase 3 path.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL3b811p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4585","BK4112","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","BK4007","IE00B3QW5Z07.USD","SG9999014021.USD","LU2095319765.USD","NDAQ","IE00BGHQF748.EUR","BK4588","LU2210149790.SGD","SG9999014039.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":82,"code":"91000000","status":"200"}]}}